Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30167% above fair value
$10.62−0.15 (-1.39%)
Close on Nov 19, 2026Market cap $585.03MP/E –Yield –
Sight Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sight Sciences's revenue for the twelve months ending Jun 30, 2026 was $83.38M, up 9.3% year over year. For fiscal 2025 it was $77.36M, down 3.1% from the year before. The highest annual figure on record is $81.06M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.36M | -3.1% |
| FY2024 | Dec 31, 2024 | $79.87M | -1.5% |
| FY2023 | Dec 31, 2023 | $81.06M | +13.6% |
| FY2022 | Dec 31, 2022 | $71.33M | +45.7% |
| FY2021 | Dec 31, 2021 | $48.96M | +77.1% |
| FY2020 | Dec 31, 2020 | $27.64M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.39M | +19.5% |
| Q1 FY2026 | Mar 31, 2026 | $19.70M | +12.5% |
| Q4 FY2025 | Dec 31, 2025 | $20.39M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $19.91M | -1.2% |
| Q2 FY2025 | Jun 30, 2025 | $19.56M | -8.5% |
| Q1 FY2025 | Mar 31, 2025 | $17.51M | -9.1% |
| Q4 FY2024 | Dec 31, 2024 | $19.07M | +1.7% |
| Q3 FY2024 | Sep 30, 2024 | $20.16M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | $21.37M | -9.0% |
| Q1 FY2024 | Mar 31, 2024 | $19.27M | +2.3% |
| Q4 FY2023 | Dec 31, 2023 | $18.75M | -8.7% |
| Q3 FY2023 | Sep 30, 2023 | $20.01M | +7.1% |
| Q2 FY2023 | Jun 30, 2023 | $23.47M | +36.2% |
| Q1 FY2023 | Mar 31, 2023 | $18.82M | +26.5% |
| Q4 FY2022 | Dec 31, 2022 | $20.54M | +39.9% |
| Q3 FY2022 | Sep 30, 2022 | $18.68M | +42.6% |
| Q2 FY2022 | Jun 30, 2022 | $17.23M | +37.4% |
| Q1 FY2022 | Mar 31, 2022 | $14.88M | +72.3% |
| Q4 FY2021 | Dec 31, 2021 | $14.69M | +63.3% |
| Q3 FY2021 | Sep 30, 2021 | $13.10M | +51.4% |
| Q2 FY2021 | Jun 30, 2021 | $12.54M | +257.9% |
| Q1 FY2021 | Mar 31, 2021 | $8.64M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.99M | – |
| Q3 FY2020 | Sep 30, 2020 | $8.65M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.50M | – |
See a number that looks wrong?